Bio-Rad Laboratories, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US0905722072
USD
269.48
8.24 (3.15%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
693.20
653.00
651.60
585.40
667.50
649.73
638.48
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
693.20
653.00
651.60
585.40
667.50
649.73
638.48
Raw Material Cost
348.40
310.20
306.20
274.80
312.40
293.83
282.76
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
12.10
12.30
12.60
12.00
12.20
12.17
12.26
Selling and Distribution Expenses
216.90
205.80
205.10
193.50
202.50
200.44
196.12
Other Expenses
5.39
5.83
4.82
4.82
5.56
4.89
4.70
Total Expenditure (Excl Depreciation)
631.30
586.60
572.10
528.50
582.70
555.36
538.18
Operating Profit (PBDIT) excl Other Income
61.900000000000006
66.39999999999999
79.5
56.900000000000006
84.80000000000001
94.39999999999999
100.3
Other Income
30.70
12.60
15.10
39.90
21.40
16.44
19.84
Operating Profit (PBDIT)
145.00
133.20
145.20
145.00
155.50
159.91
166.74
Interest
12.10
12.30
12.60
12.00
12.20
12.17
12.26
Exceptional Items
848.70
-497.80
332.00
-1.40
-1,002.90
762.99
-2,894.16
Gross Profit (PBDT)
344.80
342.80
345.40
310.60
355.10
355.90
355.72
Depreciation
52.40
54.20
50.60
48.20
49.30
49.10
46.60
Profit Before Tax
929.20
-431.10
414.00
83.40
-908.90
861.62
-2,786.28
Tax
209.20
-89.20
96.20
19.40
-193.10
208.45
-620.79
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
720.00
-341.90
317.80
64.00
-715.80
653.17
-2,165.49
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
720.00
-341.90
317.80
64.00
-715.80
653.17
-2,165.49
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
720.00
-341.90
317.80
64.00
-715.80
653.17
-2,165.49
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
7,453.60
6,736.80
7,128.70
6,679.40
6,569.30
7,487.86
6,778.79
Earnings per share (EPS)
26.65
-12.7
11.67
2.29
-25.57
23.34
-76.26
Diluted Earnings per share
26.65
-12.7
11.67
2.29
-25.57
23.34
-76.26
Operating Profit Margin (Excl OI)
8.93%
10.17%
12.2%
9.72%
12.7%
14.52%
15.71%
Gross Profit Margin
141.6%
-57.72%
71.3%
22.48%
-128.78%
140.17%
-429.1%
PAT Margin
103.87%
-52.36%
48.77%
10.93%
-107.24%
100.53%
-339.16%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is 6.16% vs 0.21% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is 310.59% vs -207.58% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is -5.22% vs -7.30% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is -1.63% vs -2.38% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

Compare Quarterly Results Of Bio-Rad Laboratories, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
693.20
540.42
152.78
28.27%
Other Operating Income
0.00
0.00
0.00
Total Operating income
693.20
540.42
152.78
28.27%
Raw Material Cost
348.40
200.24
148.16
73.99%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
12.10
10.14
1.96
19.33%
Selling and Distribution Expenses
216.90
153.88
63.02
40.95%
Other Expenses
5.39
3.71
1.68
45.28%
Total Expenditure (Excl Depreciation)
631.30
401.35
229.95
57.29%
Operating Profit (PBDIT) excl Other Income
61.90
139.07
-77.17
-55.49%
Other Income
30.70
19.87
10.83
54.50%
Operating Profit (PBDIT)
145.00
141.75
3.25
2.29%
Interest
12.10
10.14
1.96
19.33%
Exceptional Items
848.70
-22.44
871.14
3,882.09%
Gross Profit (PBDT)
344.80
340.18
4.62
1.36%
Depreciation
52.40
0.00
52.40
Profit Before Tax
929.20
109.17
820.03
751.15%
Tax
209.20
1.34
207.86
15,511.94%
Provisions and contingencies
0
0
0.00
Profit After Tax
720.00
107.83
612.17
567.72%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
720.00
107.83
612.17
567.72%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
720.00
107.83
612.17
567.72%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
7,453.60
3,778.15
3,675.45
97.28%
Earnings per share (EPS)
26.65
0.52
26.13
5,025.00%
Diluted Earnings per share
26.65
0.52
26.13
5,025.00%
Operating Profit Margin (Excl OI)
8.93%
22.55%
0.00
-13.62%
Gross Profit Margin
141.60%
20.20%
0.00
121.40%
PAT Margin
103.87%
19.95%
0.00
83.92%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 69.32 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 6.16% vs 0.21% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 3.85% vs -2.01% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 72.00 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 310.59% vs -207.58% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 200.59% vs -304.69% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 11.43 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -5.22% vs -7.30% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -14.77% vs -11.07% in Dec 2024

Quarterly - Interest
Interest 1.21 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -1.63% vs -2.38% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -0.82% vs -1.61% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.93%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024